AKBA icon

Akebia Therapeutics

90 hedge funds and large institutions have $16.5M invested in Akebia Therapeutics in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 32 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

18% less capital invested

Capital invested by funds: $20.2M → $16.5M (-$3.69M)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

47% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 32

Holders
90
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$292K
Puts
$47K
Net Calls
Net Calls Change

Top Buyers

1 +$485K
2 +$400K
3 +$154K
4
Two Sigma Investments
Two Sigma Investments
New York
+$102K
5
Marshall Wace
Marshall Wace
United Kingdom
+$101K

Top Sellers

1 -$973K
2 -$593K
3 -$322K
4
AQR Capital Management
AQR Capital Management
Connecticut
-$304K
5
E
Ergoteles
New York
-$215K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$79K
27
$76K
28
$68K
29
$66K
30
$63K
31
$60K
32
$58K
33
$54K
34
$52K
35
$52K
36
$52K
37
$46K
38
$42K
39
$41K
40
$26K
41
$24K
42
$23K
43
$22K
44
$22K
45
$21K
46
$16K
47
$16K
48
$15K
49
$14K
50
$13K